BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3332096)

  • 1. Immunologic classification of lymphoma and lymphoid leukemia.
    Foon KA; Gale RP
    Blood Rev; 1987 Jun; 1(2):77-88. PubMed ID: 3332096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic classification of leukemia and lymphoma.
    Foon KA; Todd RF
    Blood; 1986 Jul; 68(1):1-31. PubMed ID: 2941082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodgkin's lymphomas.
    Foon KA
    Curr Probl Cancer; 1989; 13(2):57-128. PubMed ID: 2659257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the immunologic classification of leukemia.
    Foon KA; Gale RP; Todd RF
    Semin Hematol; 1986 Oct; 23(4):257-83. PubMed ID: 3095928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
    Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
    Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
    Watanabe S; Shimosato Y; Shimoyama M; Minato K
    Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiological, clinical and prognostic significance of the T-B immunological classification of primary acute lymphoid leukemias and non Hodgkin's lymphomas.
    Belpomme D; Lelarge N; Mathé G; Davies AJ
    Haematol Blood Transfus; 1977; 20():33-45. PubMed ID: 305400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
    Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
    Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic classification of acute lymphoblastic leukemia. Implications for normal lymphoid differentiation.
    Foon KA; Billing RJ; Terasaki PI; Cline MJ
    Blood; 1980 Dec; 56(6):1120-6. PubMed ID: 6969097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation.
    Harris NL; Bhan AK
    Hum Pathol; 1985 Aug; 16(8):829-37. PubMed ID: 3926626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers.
    Knowles DM; Halper JP; Azzo W; Wang CY
    Cancer; 1983 Oct; 52(8):1369-77. PubMed ID: 6193856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface markers in leukemia: biological and clinical correlations.
    Thiel E
    Crit Rev Oncol Hematol; 1985; 2(3):209-60. PubMed ID: 3013441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of cellular differentiation in acute lymphoblastic leukemia.
    Peiper SC; Stass SA
    Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.